Investigator Initiated Studies (IIS) supports investigators conducting clinical studies of Genentech medicines to deepen understanding of treatments, improve patient care and generate disease-related research.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator-Initiated Studies supports physicians and researchers conducting studies of AbbVie products and therapeutic interests to expand scientific knowledge and inform patient care.
Investigator Initiated Studies support independent investigators and institutions conducting clinical and basic science research to advance knowledge of CSL products and the diseases they treat.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.
Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.